1. Home
  2. GHRS vs UDMY Comparison

GHRS vs UDMY Comparison

Compare GHRS & UDMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GHRS
  • UDMY
  • Stock Information
  • Founded
  • GHRS 2018
  • UDMY 2009
  • Country
  • GHRS Ireland
  • UDMY United States
  • Employees
  • GHRS N/A
  • UDMY 1246
  • Industry
  • GHRS Biotechnology: Pharmaceutical Preparations
  • UDMY Other Consumer Services
  • Sector
  • GHRS Health Care
  • UDMY Real Estate
  • Exchange
  • GHRS Nasdaq
  • UDMY Nasdaq
  • Market Cap
  • GHRS 960.2M
  • UDMY 1.1B
  • IPO Year
  • GHRS 2021
  • UDMY 2021
  • Fundamental
  • Price
  • GHRS $14.38
  • UDMY $7.75
  • Analyst Decision
  • GHRS Strong Buy
  • UDMY Buy
  • Analyst Count
  • GHRS 8
  • UDMY 10
  • Target Price
  • GHRS $30.63
  • UDMY $9.78
  • AVG Volume (30 Days)
  • GHRS 353.0K
  • UDMY 1.3M
  • Earning Date
  • GHRS 09-02-2025
  • UDMY 07-30-2025
  • Dividend Yield
  • GHRS N/A
  • UDMY N/A
  • EPS Growth
  • GHRS N/A
  • UDMY N/A
  • EPS
  • GHRS N/A
  • UDMY N/A
  • Revenue
  • GHRS N/A
  • UDMY $790,019,000.00
  • Revenue This Year
  • GHRS N/A
  • UDMY $1.87
  • Revenue Next Year
  • GHRS N/A
  • UDMY $4.15
  • P/E Ratio
  • GHRS N/A
  • UDMY N/A
  • Revenue Growth
  • GHRS N/A
  • UDMY 5.43
  • 52 Week Low
  • GHRS $6.00
  • UDMY $5.68
  • 52 Week High
  • GHRS $20.50
  • UDMY $10.61
  • Technical
  • Relative Strength Index (RSI)
  • GHRS 46.75
  • UDMY 62.03
  • Support Level
  • GHRS $12.81
  • UDMY $6.94
  • Resistance Level
  • GHRS $15.28
  • UDMY $7.90
  • Average True Range (ATR)
  • GHRS 1.49
  • UDMY 0.34
  • MACD
  • GHRS -0.41
  • UDMY 0.06
  • Stochastic Oscillator
  • GHRS 20.60
  • UDMY 77.50

About GHRS GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

About UDMY Udemy Inc.

Udemy Inc operates a marketplace platform at the center of a vibrant knowledge network. The company operates under two operating and reportable segments Consumer and Enterprise, out of which the Enterprise segment derives the maximum revenue. Geographically, the company derives maximum revenue from North America. The company leverages data, technology, and insights for effective learning experiences. It helps individuals and organizations to possess effective skill acquisition and development with flexibility.

Share on Social Networks: